Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.

[1]  L. Collette,et al.  EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. , 2016, European urology.

[2]  Guangtao Zhai,et al.  Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective , 2018, European Radiology.

[3]  C. Dinney,et al.  New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine , 2011, Clinical Cancer Research.

[4]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[5]  T. Takahara,et al.  DWI as an Imaging Biomarker for Bladder Cancer. , 2017, AJR. American journal of roentgenology.

[6]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  T. Uno,et al.  Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection? , 2012, European journal of radiology.

[8]  Yair Lotan,et al.  Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. , 2006, The Journal of urology.

[9]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[10]  Yuta Shibamoto,et al.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. , 2009, Radiology.

[11]  S. Barni,et al.  Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis. , 2014, European urology.

[12]  Kazutaka Saito,et al.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness , 2011, European Radiology.

[13]  Qiu-ying Yao,et al.  Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer , 2019, European Radiology.

[14]  Michael W Kattan,et al.  Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Yair Lotan,et al.  Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. , 2015, European urology.

[16]  Kazutaka Saito,et al.  Clinical Investigation : Genitourinary Cancer Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer , 2012 .

[17]  Zhengrong Liang,et al.  Radiomics assessment of bladder cancer grade using texture features from diffusion‐weighted imaging , 2017, Journal of magnetic resonance imaging : JMRI.

[18]  L. Martínez-Piñeiro,et al.  Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. , 2009, The Journal of urology.

[19]  M. Huang,et al.  Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer , 2018, EBioMedicine.

[20]  R. Tibshirani.  The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.

[21]  Zhengrong Liang,et al.  A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors , 2019, Journal of magnetic resonance imaging : JMRI.

[22]  C. Drake,et al.  Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy. , 2018, Urology.

[23]  H. Klingler,et al.  Apparent diffusion coefficient values obtained by unenhanced MRI predicts disease-specific survival in bladder cancer. , 2018, Clinical radiology.

[24]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[25]  Guangtao Zhai,et al.  A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme , 2017, Scientific Reports.

[26]  S. Lerner.  Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelines , 2016, Nature Reviews Urology.

[27]  M. Milowsky,et al.  Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Andriy Fedorov,et al.  Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.

[29]  Y. Lotan,et al.  Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder , 2013, British Journal of Cancer.

[30]  T. Niu,et al.  Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI , 2016, Clinical Cancer Research.

[31]  J. Witjes,et al.  MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER , 2016 .

[32]  A. Vickers,et al.  Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. , 2015, European urology.

[33]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[34]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[35]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[36]  C. Vale.  Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .

[37]  Tianxin Lin,et al.  A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer , 2017, Clinical Cancer Research.

[38]  M. Milowsky,et al.  Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. , 2009, European urology.

[39]  F. Montorsi,et al.  Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature , 2017, World Journal of Urology.

[40]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.